UFP Technologies Competitors

UFP Technologies (NASDAQ:UFPT) and MiMedx Group (NASDAQ:MDXG) are both small-cap industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Insider & Institutional Ownership

76.1% of UFP Technologies shares are held by institutional investors. Comparatively, 4.0% of MiMedx Group shares are held by institutional investors. 11.0% of UFP Technologies shares are held by company insiders. Comparatively, 19.8% of MiMedx Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares UFP Technologies and MiMedx Group's net margins, return on equity and return on assets.

Risk and Volatility

UFP Technologies has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.71, meaning that its stock price is 71% more volatile than the S&P 500.

Valuation & Earnings

This table compares UFP Technologies and MiMedx Group's revenue, earnings per share and valuation.

UFP Technologies has higher earnings, but lower revenue than MiMedx Group.

Analyst Ratings

This is a summary of recent ratings and target prices for UFP Technologies and MiMedx Group, as reported by MarketBeat.

MiMedx Group has a consensus target price of $20.00, indicating a potential upside of 84.50%. Given MiMedx Group's higher possible upside, analysts clearly believe MiMedx Group is more favorable than UFP Technologies.

Summary

UFP Technologies beats MiMedx Group on 7 of the 12 factors compared between the two stocks.

UFP Technologies (NASDAQ:UFPT) and Atrion (NASDAQ:ATRI) are both small-cap industrial products companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.

Analyst Ratings

This is a breakdown of recent ratings for UFP Technologies and Atrion, as provided by MarketBeat.

Profitability

This table compares UFP Technologies and Atrion's net margins, return on equity and return on assets.

Institutional and Insider Ownership

76.1% of UFP Technologies shares are held by institutional investors. Comparatively, 63.2% of Atrion shares are held by institutional investors. 11.0% of UFP Technologies shares are held by insiders. Comparatively, 22.4% of Atrion shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Risk & Volatility

UFP Technologies has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, Atrion has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500.

Valuation and Earnings

This table compares UFP Technologies and Atrion's revenue, earnings per share and valuation.

Atrion has lower revenue, but higher earnings than UFP Technologies.

Summary

Atrion beats UFP Technologies on 7 of the 11 factors compared between the two stocks.

UFP Technologies (NASDAQ:UFPT) and SI-BONE (NASDAQ:SIBN) are both small-cap industrial products companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations.

Risk & Volatility

UFP Technologies has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, SI-BONE has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500.

Profitability

This table compares UFP Technologies and SI-BONE's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and recommmendations for UFP Technologies and SI-BONE, as reported by MarketBeat.com.

SI-BONE has a consensus target price of $33.20, indicating a potential downside of 0.75%. Given SI-BONE's higher probable upside, analysts clearly believe SI-BONE is more favorable than UFP Technologies.

Valuation & Earnings

This table compares UFP Technologies and SI-BONE's top-line revenue, earnings per share (EPS) and valuation.

UFP Technologies has higher revenue and earnings than SI-BONE. SI-BONE is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

76.1% of UFP Technologies shares are owned by institutional investors. Comparatively, 65.3% of SI-BONE shares are owned by institutional investors. 11.0% of UFP Technologies shares are owned by company insiders. Comparatively, 15.5% of SI-BONE shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

UFP Technologies beats SI-BONE on 8 of the 13 factors compared between the two stocks.

UFP Technologies (NASDAQ:UFPT) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ownership and dividends.

Volatility and Risk

UFP Technologies has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500.

Valuation and Earnings

This table compares UFP Technologies and Tactile Systems Technology's revenue, earnings per share and valuation.

UFP Technologies has higher revenue and earnings than Tactile Systems Technology. UFP Technologies is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares UFP Technologies and Tactile Systems Technology's net margins, return on equity and return on assets.

Insider and Institutional Ownership

76.1% of UFP Technologies shares are held by institutional investors. 11.0% of UFP Technologies shares are held by company insiders. Comparatively, 5.3% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for UFP Technologies and Tactile Systems Technology, as reported by MarketBeat.com.

Tactile Systems Technology has a consensus target price of $59.00, indicating a potential upside of 9.44%. Given Tactile Systems Technology's higher possible upside, analysts plainly believe Tactile Systems Technology is more favorable than UFP Technologies.

Summary

UFP Technologies beats Tactile Systems Technology on 10 of the 13 factors compared between the two stocks.

LeMaitre Vascular (NASDAQ:LMAT) and UFP Technologies (NASDAQ:UFPT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

Institutional and Insider Ownership

84.2% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 76.1% of UFP Technologies shares are owned by institutional investors. 16.5% of LeMaitre Vascular shares are owned by company insiders. Comparatively, 11.0% of UFP Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and price targets for LeMaitre Vascular and UFP Technologies, as reported by MarketBeat.com.

LeMaitre Vascular currently has a consensus target price of $36.60, indicating a potential downside of 26.89%. Given LeMaitre Vascular's higher probable upside, research analysts plainly believe LeMaitre Vascular is more favorable than UFP Technologies.

Profitability

This table compares LeMaitre Vascular and UFP Technologies' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares LeMaitre Vascular and UFP Technologies' gross revenue, earnings per share and valuation.

UFP Technologies has higher revenue and earnings than LeMaitre Vascular. UFP Technologies is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

LeMaitre Vascular has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Comparatively, UFP Technologies has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.

Summary

LeMaitre Vascular beats UFP Technologies on 9 of the 13 factors compared between the two stocks.

OrthoPediatrics (NASDAQ:KIDS) and UFP Technologies (NASDAQ:UFPT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Valuation & Earnings

This table compares OrthoPediatrics and UFP Technologies' gross revenue, earnings per share (EPS) and valuation.

UFP Technologies has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

OrthoPediatrics has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Comparatively, UFP Technologies has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

Institutional and Insider Ownership

71.7% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 76.1% of UFP Technologies shares are owned by institutional investors. 33.6% of OrthoPediatrics shares are owned by company insiders. Comparatively, 11.0% of UFP Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares OrthoPediatrics and UFP Technologies' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings for OrthoPediatrics and UFP Technologies, as provided by MarketBeat.com.

OrthoPediatrics currently has a consensus price target of $58.1429, suggesting a potential upside of 11.90%. Given OrthoPediatrics' higher probable upside, equities analysts clearly believe OrthoPediatrics is more favorable than UFP Technologies.

Summary

UFP Technologies beats OrthoPediatrics on 9 of the 13 factors compared between the two stocks.